Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma.

J Exp Clin Cancer Res · 2022 · PMC9047373 · PMID 35477411

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

WASF2 -related gene signatures were enriched in the majority of the cancer-associated pathways; G2M_CHECKPOINT was identified as a highly significant enriched gene set (Fig.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.